Blau Farmaceutical S.A

Blau is a leading pharmaceutical company in its institutional market segment and a biotechnology pioneer among Brazilian companies, with its own portfolio of high-complexity drugs focused on immunology, hematology, oncology, nephrology, infectious diseases and anesthesiology. The company has a continental footprint, operating across seven South American countries — Argentina, Brazil, Chile, Colombia, Ecuador, Peru and Uruguay — as well as in the USA.